Literature DB >> 3182107

Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma.

E Oosterwijk1, S O Warnaar, J Zwartendijk, E A van der Velde, G J Fleuren, C J Cornelisse.   

Abstract

Tumor ploidy and expression of renal differentiation antigens as recognized by a previously described series of monoclonal antibodies (MAbs) (RC2, RC3, RC4, RC38, RC69, RC154 and G250) were assessed in 48 renal-cell carcinomas. A positive association was found between aneuploidy and development of metastases. Aneuploid tumors showed a loss of antigen expression more frequently than diploid tumors. This difference was statistically significant for antigens recognized by RC3 and RC69. Loss of RC154 reactivity was associated with increased metastatic potential. Clinical stage was the most powerful single prognostic variable but ploidy and RC3 reactivity carried additional prognostic information.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182107     DOI: 10.1002/ijc.2910420512

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index.

Authors:  J P Volpe; I Basic; L Milas
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

2.  Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster lymphoma and its liver metastasis using image analysis techniques.

Authors:  M S Lakshmi; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

3.  Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.

Authors:  A K el-Naggar; J G Batsakis; K Teague; G Giacco; V F Guinee; D Swanson
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

Review 4.  Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Authors:  A P Zbar; N R Lemoine; M Wadhwa; H Thomas; D Snary; W A Kmiot
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.